TickerFacts.

Neumora Therapeutics, Inc. (NMRA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

163.39M
Year ended 2025-12-31
+81.8%
3-year compound annual growth
2022-12-31: 27.21M2023-12-31: 65.02M2024-12-31: 159.38M2025-12-31: 163.39M163.39M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31163.39M+2.5%2026-03-30, From 2025-01-01
2024-12-31159.38M+145.1%2026-03-30, From 2024-01-01
2023-12-3165.02M+139.0%2025-03-03, From 2023-01-01
2022-12-3127.21Mn/a2025-03-03, From 2022-01-01